References
- Golub T. R., Slonim D. K., Tamayo P., Huard C., Gaasenbeek M., Mesirov J. P., et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531–7
- Emmert‐Buck M. R., Strausberg R. L., Krizman D. B., Bonaldo M. F., Bonner R. F., Bostwick D. G., et al. Molecular profiling of clinical tissues specimens: feasibility and applications. J Mol Diagn 2000; 2: 60–6
- Alizadeh A. A., Ross D. T., Perou C. M., van de Rijn M. Towards a novel classification of human malignancies based on gene expression patterns. J Pathol 2001; 195: 41–52
- Cronin M., Pho M., Dutta D., Stephans J. C., Shak S., Kiefer M. C., et al. Measurement of gene expression in archival paraffin‐embedded tissues: development and performance of a 92‐gene reverse transcriptase‐polymerase chain reaction assay. Am J Pathol 2004; 164: 35–42
- Bertucci F., Salas S., Eysteries S., Nasser V., Finetti P., Ginestier C., et al. Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 2004; 23: 1377–91
- Lossos I. S., Czerwinski D. K., Alizadeh A. A., Wechser M. A., Tibshirani R., Botstein D., et al. Prediction of survival in diffuse large‐B‐cell lymphoma based on the expression of six genes. N Engl J Med 2004; 350: 1828–37
- Bustin S. A. Absolute quantification of mRNA using real‐time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000; 25: 169–93
- Bernard P. S., Wittwer C. T. Real‐time PCR technology for cancer diagnostics. Clin Chem 2002; 48: 1178–85
- Zenilman M. E., Graham W., Tanner K., Shuldiner A. R. Competitive reverse‐transcriptase polymerase chain reaction without an artificial internal standard. Anal Biochem 1995; 224: 339–46
- Joo C. H., Lee H., Kim E., Lee B., Cho Y. K., Kim Y. K. Differential amplifying RT‐PCR: a novel RT‐PCR method to differentiate mRNA from its DNA lacking intron. J Virol Methods 2002; 100: 71–81
- Stenman J., Paju A., Rissanen O., Orpana A. European Patent Register; Pending. Method for quantitative and/or comparative measurement of mRNA expression levels in small biological samples., Patent application number WO 2005116248. Date issued 2005‐05‐25
- Zeng Z. S., Huang Y., Cohen A. M., Guillem J. G. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase‐9. J Clin Oncol 1996; 14: 3133–40
- Yang J. L., Seetoo D., Wang Y., Ranson M., Berney C. R., Ham J. M., et al. Urokinase‐type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer‐specific survival and potential therapeutic targets. Int J Cancer 2000; 89: 431–9
- Yamamoto H., Iku S., Adachi Y., Imsumran A., Taniguchi H., Nosho K., et al. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer. J Pathol 2003; 199: 176–84
- Parc Y., Gueroult S., Mourra N., Serfaty L., Flejou J. F., Tiret E., et al. Prognostic significance of microsatellite instability determined by immunohistochemical staining of MSH2 and MLH1 in sporadic T3N0M0 colon cancer. Gut 2004; 53: 371–5
- Stenman J., Paju A., Rissanen O., Tenkanen T., Haglund C., Stenman U. ‐H., et al. Targeted gene‐expression analysis by genome‐controlled RT‐PCR. Clin Chem, In press
- Wittwer C. T., Reed G. H., Gundry C. N., Vandersteen J. G., Pryor R. J. High‐resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem 2003; 49: 853–60